Literature DB >> 33132780

L-Methylfolate as a Monotherapy for Treatment-Resistant Depression: A Case Study.

Angela Hardin1, Carrie Baldwin-Sayre1.   

Abstract

This case study examines a 49-year-old Asian American female patient with long-standing fatigue and depression (20 years or more), for which pharmaceutical antidepressant therapies have been ineffective. History, physical examination, laboratory tests, and Genomind Genecept Assay genetic testing were used to determine symptom severity, investigate the presence of organic causes of fatigue, and provide a potential novel monotherapy for depression. Therapeutic intervention included a slow titration of L-methylfolate to an eventual therapeutic daily dose of 15 mg.
Copyright © 2020 InnoVision Professional Media Inc.

Entities:  

Year:  2020        PMID: 33132780      PMCID: PMC7572139     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  9 in total

Review 1.  Depression.

Authors:  Gin S Malhi; J John Mann
Journal:  Lancet       Date:  2018-11-02       Impact factor: 79.321

2.  STAR*D: what have we learned?

Authors:  A John Rush
Journal:  Am J Psychiatry       Date:  2007-02       Impact factor: 18.112

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 4.  Issues in treatment-resistant depression.

Authors:  Martin B Keller
Journal:  J Clin Psychiatry       Date:  2005       Impact factor: 4.384

Review 5.  Enhancement of recovery from mental illness with l-methylfolate supplementation.

Authors:  Gerald Martone
Journal:  Perspect Psychiatr Care       Date:  2017-06-08       Impact factor: 2.186

6.  STAR*D: revising conventional wisdom.

Authors:  A John Rush; Diane Warden; Stephen R Wisniewski; Maurizio Fava; Madhukar H Trivedi; Bradley N Gaynes; Andrew A Nierenberg
Journal:  CNS Drugs       Date:  2009-08       Impact factor: 5.749

7.  L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.

Authors:  George I Papakostas; Richard C Shelton; John M Zajecka; Bijan Etemad; Karl Rickels; Alisabet Clain; Lee Baer; Elizabeth D Dalton; Garret R Sacco; David Schoenfeld; Michael Pencina; Allison Meisner; Teodoro Bottiglieri; Erik Nelson; David Mischoulon; Jonathan E Alpert; James G Barbee; Sidney Zisook; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2012-12       Impact factor: 18.112

Review 8.  The assessment and treatment of refractory depression.

Authors:  K A Phillips; A A Nierenberg
Journal:  J Clin Psychiatry       Date:  1994-02       Impact factor: 4.384

9.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.